Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2021

02.06.2021 | Retinal Disorders

Persistent macular holes — what is the best strategy for revision?

verfasst von: Peter Szurman, Philip Wakili, Boris V. Stanzel, Rudolf Siegel, Karl T. Boden, Annekatrin Rickmann

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to analyze the success rate and functional outcome after revision surgery of persistent idiopathic full-thickness macular holes in a large patient cohort and to identify the optimal tamponade strategy and the value of new adjunctive manipulation techniques for persistent macular hole (pMH) closure.

Methods

Retrospective, comparative, non-consecutive case series of all revisional surgeries for idiopathic pMH between 2011 and 2019 at the Eye Clinic Sulzbach were identified. Of 1163 idiopathic MH surgeries, 74 eyes of 74 patients had pMH. Of those, group 1 (n = 38) had vitrectomy with tamponade alone (20% sulfur hexafluoride gas, 15% hexafluoroethane gas, silicone oil 5000, Densiron®), while group 2 (n = 36) included tamponade with adjuvant manipulation (internal limiting membrane (ILM) translocation, subretinal fluid injection, epiretinal amniotic membrane, free retina graft, or autologous blood). Main statistical outcomes were anatomic closure rate, visual acuity (VA), minimum linear diameter (MLD), and base diameter (BD).

Results

Overall total anatomical success rate was 81.1% and mean VA improved 3.5 lines from LogMAR 1.03 ± 0.30 to 0.68 ± 0.38 (p < .001). Preoperative MLD or BD had no effect on total anatomic success (p = 0.074, p = 0.134, respectively). When comparing the two groups, slightly better anatomic success rates were achieved in group 1 (84.2%) compared to that in group 2 (77.8%) (p = 0.68). Final VA in group 1 (LogMAR 0.67 ± 0.39) outperformed group 2 (LogMAR 0.86 ± 0.38) (p = 0.03).

Conclusions

Revisional surgery for persistent idiopathic MH with tamponade alone had comparable anatomical closure but better VA outcomes, compared to tamponade with adjuvant manipulation.
Literatur
1.
Zurück zum Zitat Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A (2002) Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol 134:661–666CrossRef Haritoglou C, Gass CA, Schaumberger M, Gandorfer A, Ulbig MW, Kampik A (2002) Long-term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol 134:661–666CrossRef
2.
Zurück zum Zitat Spiteri Cornish K, Lois N, Scott NW, Burr J, Cook J, Boachie C, Tadayoni R, La Cour M, Christensen U, Kwok AKH (2014) Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. Ophthalmology 121:649–655CrossRef Spiteri Cornish K, Lois N, Scott NW, Burr J, Cook J, Boachie C, Tadayoni R, La Cour M, Christensen U, Kwok AKH (2014) Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. Ophthalmology 121:649–655CrossRef
4.
Zurück zum Zitat Reid GA, McDonagh N, Wright DM, Yek JTO, Essex RW, Lois N (2020) First failed macular hole surgery or reopening of a previously closed hole: do we gain by reoperating?-A systematic review and meta-analysis. Retina 40:1–15CrossRef Reid GA, McDonagh N, Wright DM, Yek JTO, Essex RW, Lois N (2020) First failed macular hole surgery or reopening of a previously closed hole: do we gain by reoperating?-A systematic review and meta-analysis. Retina 40:1–15CrossRef
5.
Zurück zum Zitat Michalewska Z, Michalewski J, Adelman RA, Nawrocki J (2010) Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology 117:2018–2025CrossRef Michalewska Z, Michalewski J, Adelman RA, Nawrocki J (2010) Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology 117:2018–2025CrossRef
6.
Zurück zum Zitat Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Adelman RA, Nawrocki J (2015) Temporal inverted internal limiting membrane flap technique versus classic inverted internal limiting membrane flap technique: a comparative study. Retina 35:1844–1850CrossRef Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Adelman RA, Nawrocki J (2015) Temporal inverted internal limiting membrane flap technique versus classic inverted internal limiting membrane flap technique: a comparative study. Retina 35:1844–1850CrossRef
7.
Zurück zum Zitat Morizane Y, Shiraga F, Kimura S, Hosokawa M, Shiode Y, Kawata T, Hosogi M, Shirakata Y, Okanouchi T (2014) Autologous transplantation of the internal limiting membrane for refractory macular holes. Am J Ophthalmol 157:861-869.e1CrossRef Morizane Y, Shiraga F, Kimura S, Hosokawa M, Shiode Y, Kawata T, Hosogi M, Shirakata Y, Okanouchi T (2014) Autologous transplantation of the internal limiting membrane for refractory macular holes. Am J Ophthalmol 157:861-869.e1CrossRef
8.
Zurück zum Zitat Dai Y, Dong F, Zhang X, Yang Z (2016) Internal limiting membrane transplantation for unclosed and large macular holes. Graefe’s Arch Clin Exp Ophthalmol 254:2095–2099CrossRef Dai Y, Dong F, Zhang X, Yang Z (2016) Internal limiting membrane transplantation for unclosed and large macular holes. Graefe’s Arch Clin Exp Ophthalmol 254:2095–2099CrossRef
9.
Zurück zum Zitat Ozdek S, Baskaran P, Karabas L, Neves PP (2017) A modified perfluoro-n-octane-assisted autologous internal limiting membrane transplant for failed macular hole reintervention: a case series. Ophthalmic Surg Lasers Imaging Retina 48:416–420CrossRef Ozdek S, Baskaran P, Karabas L, Neves PP (2017) A modified perfluoro-n-octane-assisted autologous internal limiting membrane transplant for failed macular hole reintervention: a case series. Ophthalmic Surg Lasers Imaging Retina 48:416–420CrossRef
10.
Zurück zum Zitat Pires J, Nadal J, Gomes NL (2017) Internal limiting membrane translocation for refractory macular holes. Br J Ophthalmol 101:377–382PubMed Pires J, Nadal J, Gomes NL (2017) Internal limiting membrane translocation for refractory macular holes. Br J Ophthalmol 101:377–382PubMed
11.
Zurück zum Zitat Szigiato A-A, Gilani F, Walsh MK, Mandelcorn ED, Muni RH (2016) Induction of macular detachment for the treatment of persistent or recurrent idiopathic macular holes. Retina 36:1694–1698CrossRef Szigiato A-A, Gilani F, Walsh MK, Mandelcorn ED, Muni RH (2016) Induction of macular detachment for the treatment of persistent or recurrent idiopathic macular holes. Retina 36:1694–1698CrossRef
12.
Zurück zum Zitat Gurelik G, Sul S, Kılıç G, Özsaygılı C (2017) A modified foveal advancement technique in the treatment of persistent large macular holes. Ophthalmic Surg Lasers Imaging Retina 48:793–798CrossRef Gurelik G, Sul S, Kılıç G, Özsaygılı C (2017) A modified foveal advancement technique in the treatment of persistent large macular holes. Ophthalmic Surg Lasers Imaging Retina 48:793–798CrossRef
13.
Zurück zum Zitat Meyer CH, Szurman P, Haritoglou C, Maier M, Wolf A, Lytvynchuk L, Priglinger S, Hillenkamp J, Wachtlin J, Becker M, Mennel S, Koss MJ (2020) Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study. Graefe’s Arc Clin Exp Ophthalmol 258:2151–2161CrossRef Meyer CH, Szurman P, Haritoglou C, Maier M, Wolf A, Lytvynchuk L, Priglinger S, Hillenkamp J, Wachtlin J, Becker M, Mennel S, Koss MJ (2020) Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study. Graefe’s Arc Clin Exp Ophthalmol 258:2151–2161CrossRef
14.
Zurück zum Zitat Rizzo S, Caporossi T, Tartaro R, Finocchio L, Franco F, Barca F, Giansanti F (2019) A human amniotic membrane plug to promote retinal breaks repair and recurrent macular hole closure. Retina 39(Suppl 1):S95–S103CrossRef Rizzo S, Caporossi T, Tartaro R, Finocchio L, Franco F, Barca F, Giansanti F (2019) A human amniotic membrane plug to promote retinal breaks repair and recurrent macular hole closure. Retina 39(Suppl 1):S95–S103CrossRef
15.
Zurück zum Zitat Moharram HM, Moustafa MT, Mortada HA, Abdelkader MF (2020) Use of epimacular amniotic membrane graft in cases of recurrent retinal detachment due to failure of myopic macular hole closure. Ophthalmic Surg Lasers Imaging Retina 51:101–108CrossRef Moharram HM, Moustafa MT, Mortada HA, Abdelkader MF (2020) Use of epimacular amniotic membrane graft in cases of recurrent retinal detachment due to failure of myopic macular hole closure. Ophthalmic Surg Lasers Imaging Retina 51:101–108CrossRef
16.
Zurück zum Zitat Thomas AS, Mahmoud TH (2018) Subretinal transplantation of an autologous retinal free flap for chronic retinal detachment with proliferative vitreoretinopathy with and without macular hole. Retina 38(Suppl 1):S121–S124CrossRef Thomas AS, Mahmoud TH (2018) Subretinal transplantation of an autologous retinal free flap for chronic retinal detachment with proliferative vitreoretinopathy with and without macular hole. Retina 38(Suppl 1):S121–S124CrossRef
17.
Zurück zum Zitat Grewal DS, Charles S, Parolini B, Kadonosono K, Mahmoud TH (2019) Autologous retinal transplant for refractory macular holes: Multicenter International Collaborative Study Group. Ophthalmology 126:1399–1408CrossRef Grewal DS, Charles S, Parolini B, Kadonosono K, Mahmoud TH (2019) Autologous retinal transplant for refractory macular holes: Multicenter International Collaborative Study Group. Ophthalmology 126:1399–1408CrossRef
18.
Zurück zum Zitat Korobelnik J-F, Hannouche D, Belayachi N, Branger M, Guez J-E, Hoang-Xuan T (1996) Autologous platelet concentrate as an adjunct in macular hole healing. Ophthalmology 103:590–594CrossRef Korobelnik J-F, Hannouche D, Belayachi N, Branger M, Guez J-E, Hoang-Xuan T (1996) Autologous platelet concentrate as an adjunct in macular hole healing. Ophthalmology 103:590–594CrossRef
19.
Zurück zum Zitat Purtskhvanidze K, Frühsorger B, Bartsch S, Hedderich J, Roider J, Treumer F (2018) Persistent full-thickness idiopathic macular hole: anatomical and functional outcome of revitrectomy with autologous platelet concentrate or autologous whole blood. Ophthalmologica. Journal international d’ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 239:19–26PubMed Purtskhvanidze K, Frühsorger B, Bartsch S, Hedderich J, Roider J, Treumer F (2018) Persistent full-thickness idiopathic macular hole: anatomical and functional outcome of revitrectomy with autologous platelet concentrate or autologous whole blood. Ophthalmologica. Journal international d’ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 239:19–26PubMed
20.
Zurück zum Zitat Jonas JB, Jäger M (2003) Perfluorohexyloctane endotamponade for treatment of persisting macular hole. Eur J Ophthalmol 13:103–104CrossRef Jonas JB, Jäger M (2003) Perfluorohexyloctane endotamponade for treatment of persisting macular hole. Eur J Ophthalmol 13:103–104CrossRef
21.
Zurück zum Zitat Oz O, Akduman L (2003) Successful surgical repair and good visual outcome of a recurrent macular hole of seven years duration. Eur J Ophthalmol 13:588–589CrossRef Oz O, Akduman L (2003) Successful surgical repair and good visual outcome of a recurrent macular hole of seven years duration. Eur J Ophthalmol 13:588–589CrossRef
22.
Zurück zum Zitat Lappas A, Foerster AMH, Kirchhof B (2009) Use of heavy silicone oil (Densiron-68) in the treatment of persistent macular holes. Acta Ophthalmol 87:866–870CrossRef Lappas A, Foerster AMH, Kirchhof B (2009) Use of heavy silicone oil (Densiron-68) in the treatment of persistent macular holes. Acta Ophthalmol 87:866–870CrossRef
23.
Zurück zum Zitat Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli MC (2009) Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes: Densiron-68 endotamponade for persistent macular holes. Graefe’s Arch Clin Exp Ophthalmol 247:1471–1476CrossRef Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Miniaci S, Romagnoli MC (2009) Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes: Densiron-68 endotamponade for persistent macular holes. Graefe’s Arch Clin Exp Ophthalmol 247:1471–1476CrossRef
24.
Zurück zum Zitat Hillenkamp J, Kraus J, Framme C, Jackson TL, Roider J, Gabel V-P, Sachs HG (2007) Retreatment of full-thickness macular hole: predictive value of optical coherence tomography. Br J Ophthalmol 91:1445–1449CrossRef Hillenkamp J, Kraus J, Framme C, Jackson TL, Roider J, Gabel V-P, Sachs HG (2007) Retreatment of full-thickness macular hole: predictive value of optical coherence tomography. Br J Ophthalmol 91:1445–1449CrossRef
25.
Zurück zum Zitat D’Souza MJJ, Chaudhary V, Devenyi R, Kertes PJ, Lam W-C (2011) Re-operation of idiopathic full-thickness macular holes after initial surgery with internal limiting membrane peel. Br J Ophthalmol 95:1564–1567CrossRef D’Souza MJJ, Chaudhary V, Devenyi R, Kertes PJ, Lam W-C (2011) Re-operation of idiopathic full-thickness macular holes after initial surgery with internal limiting membrane peel. Br J Ophthalmol 95:1564–1567CrossRef
26.
Zurück zum Zitat Rao X, Wang N-K, Chen Y-P, Hwang Y-S, Chuang L-H, Liu I-C, Chen K-J, Wu W-C, Lai C-C (2013) Outcomes of outpatient fluid-gas exchange for open macular hole after vitrectomy. Am J Ophthalmol 156:326-333.e1CrossRef Rao X, Wang N-K, Chen Y-P, Hwang Y-S, Chuang L-H, Liu I-C, Chen K-J, Wu W-C, Lai C-C (2013) Outcomes of outpatient fluid-gas exchange for open macular hole after vitrectomy. Am J Ophthalmol 156:326-333.e1CrossRef
27.
Zurück zum Zitat Patel R, Gopalakrishnan M, Rajesh B, Giridhar A (2017) Postvitrectomy macular hole undergoing delayed closure after 28 months. Indian J Ophthalmol 65:882–884CrossRef Patel R, Gopalakrishnan M, Rajesh B, Giridhar A (2017) Postvitrectomy macular hole undergoing delayed closure after 28 months. Indian J Ophthalmol 65:882–884CrossRef
28.
Zurück zum Zitat Vishal MY, Babu N, Kohli P, Rajendran A, Ramasamy K (2018) Retrospective study of changes in ocular coherence tomography characteristics after failed macular hole surgery and outcomes of fluid-gas exchange for persistent macular hole. Indian J Ophthalmol 66:1130–1135CrossRef Vishal MY, Babu N, Kohli P, Rajendran A, Ramasamy K (2018) Retrospective study of changes in ocular coherence tomography characteristics after failed macular hole surgery and outcomes of fluid-gas exchange for persistent macular hole. Indian J Ophthalmol 66:1130–1135CrossRef
29.
Zurück zum Zitat Yek JTO, Hunyor AP, Campbell WG, McAllister IL, Essex RW (2018) Outcomes of eyes with failed primary surgery for idiopathic macular hole. Ophthalmology Retina 2:757–764CrossRef Yek JTO, Hunyor AP, Campbell WG, McAllister IL, Essex RW (2018) Outcomes of eyes with failed primary surgery for idiopathic macular hole. Ophthalmology Retina 2:757–764CrossRef
30.
Zurück zum Zitat Kitaya N, Hikichi T, Kagokawa H, Takamiya A, Takahashi A, Yoshida A (2004) Irregularity of photoreceptor layer after successful macular hole surgery prevents visual acuity improvement. Am J Ophthalmol 138:308–310CrossRef Kitaya N, Hikichi T, Kagokawa H, Takamiya A, Takahashi A, Yoshida A (2004) Irregularity of photoreceptor layer after successful macular hole surgery prevents visual acuity improvement. Am J Ophthalmol 138:308–310CrossRef
31.
Zurück zum Zitat Baba T, Yamamoto S, Arai M, Arai E, Sugawara T, Mitamura Y, Mizunoya S (2008) Correlation of visual recovery and presence of photoreceptor inner/outer segment junction in optical coherence images after successful macular hole repair. Retina 28:453–458CrossRef Baba T, Yamamoto S, Arai M, Arai E, Sugawara T, Mitamura Y, Mizunoya S (2008) Correlation of visual recovery and presence of photoreceptor inner/outer segment junction in optical coherence images after successful macular hole repair. Retina 28:453–458CrossRef
32.
Zurück zum Zitat Itoh Y, Inoue M, Rii T, Hiraoka T, Hirakata A (2012) Significant correlation between visual acuity and recovery of foveal cone microstructures after macular hole surgery. Am J Ophthalmol 153:111–9.e1CrossRef Itoh Y, Inoue M, Rii T, Hiraoka T, Hirakata A (2012) Significant correlation between visual acuity and recovery of foveal cone microstructures after macular hole surgery. Am J Ophthalmol 153:111–9.e1CrossRef
33.
Zurück zum Zitat Nowroozzadeh MH, Ashraf H, Zadmehr M, Farvardin M (2018) Outcomes of light silicone oil tamponade for failed idiopathic macular hole surgery. J Ophthalmic Vis Res 13:130–137CrossRef Nowroozzadeh MH, Ashraf H, Zadmehr M, Farvardin M (2018) Outcomes of light silicone oil tamponade for failed idiopathic macular hole surgery. J Ophthalmic Vis Res 13:130–137CrossRef
34.
Zurück zum Zitat Schaub F, Gözlügöl N, Goscinski C von, Enders P, Heindl LM, Dahlke C (2020) Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery. Eur J Ophthalmol:1120672120903704 Schaub F, Gözlügöl N, Goscinski C von, Enders P, Heindl LM, Dahlke C (2020) Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery. Eur J Ophthalmol:1120672120903704
35.
Zurück zum Zitat Cillino S, Cillino G, Ferraro LL, Casuccio A (2016) TREATMENT OF PERSISTENTLY OPEN MACULAR HOLES WITH HEAVY SILICONE OIL (DENSIRON 68) VERSUS C2F6. A PROSPECTIVE RANDOMIZED STUDY. Retina 36:688–694PubMed Cillino S, Cillino G, Ferraro LL, Casuccio A (2016) TREATMENT OF PERSISTENTLY OPEN MACULAR HOLES WITH HEAVY SILICONE OIL (DENSIRON 68) VERSUS C2F6. A PROSPECTIVE RANDOMIZED STUDY. Retina 36:688–694PubMed
36.
Zurück zum Zitat Fotis K, Alexander P, Sax J, Reddie I, Kang CY, Chandra A (2019) Macular Detachment for the Treatment of Persistent Full-Thickness Macular Holes. Retina 39(Suppl 1):S104–S107CrossRef Fotis K, Alexander P, Sax J, Reddie I, Kang CY, Chandra A (2019) Macular Detachment for the Treatment of Persistent Full-Thickness Macular Holes. Retina 39(Suppl 1):S104–S107CrossRef
37.
Zurück zum Zitat Szurman P, Roters S, Grisanti S, Aisenbrey S, Schraermeyer U, Lüke M, Bartz-Schmidt KU, Thumann G (2006) Ultrastructural changes after artificial retinal detachment with modified retinal adhesion. Invest Ophthalmol Vis Sci 47:4983–4989CrossRef Szurman P, Roters S, Grisanti S, Aisenbrey S, Schraermeyer U, Lüke M, Bartz-Schmidt KU, Thumann G (2006) Ultrastructural changes after artificial retinal detachment with modified retinal adhesion. Invest Ophthalmol Vis Sci 47:4983–4989CrossRef
Metadaten
Titel
Persistent macular holes — what is the best strategy for revision?
verfasst von
Peter Szurman
Philip Wakili
Boris V. Stanzel
Rudolf Siegel
Karl T. Boden
Annekatrin Rickmann
Publikationsdatum
02.06.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2021
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-021-05252-7

Weitere Artikel der Ausgabe 7/2021

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2021 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.